Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Backer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Protein Expression and Purification|September 26, 2001
Functionally active VEGF fusion proteinsM V Backer, J M Backer
Bioconjugate Chemistry|November 22, 2001
Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteinsM V Backer, J M Backer
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Molecular vehicle for target-mediated delivery of therapeutics and diagnosticsE K Gaidamakova, M V Backer, J M Backer
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2M V Backer, V G Budker, J M Backer
The Journal of Biological Chemistry|June 16, 2001
Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signalingQ Tao, M V Backer, J M Backer, et al.
Anticancer Research|August 6, 2000
Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuliM V Backer, N Kamel, C Sandoval, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Protein Expression and Purification|September 26, 2001
Functionally active VEGF fusion proteinsM V Backer, J M Backer
Bioconjugate Chemistry|November 22, 2001
Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteinsM V Backer, J M Backer
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Molecular vehicle for target-mediated delivery of therapeutics and diagnosticsE K Gaidamakova, M V Backer, J M Backer
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001
Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2M V Backer, V G Budker, J M Backer
The Journal of Biological Chemistry|June 16, 2001
Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signalingQ Tao, M V Backer, J M Backer, et al.
Anticancer Research|August 6, 2000
Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuliM V Backer, N Kamel, C Sandoval, et al.
Pageof 1